|
Q2 FY2015
As of Apr 30, 2015
|
Q1 FY2015
As of Jan 31, 2015
|
Q4 FY2014
As of Oct 31, 2014
|
Q3 FY2014
As of Jul 31, 2014
|
Q2 FY2014
As of Apr 30, 2014
|
Q1 FY2014
As of Jan 31, 2014
|
Q4 FY2013
As of Oct 31, 2013
|
Q3 FY2013
As of Jul 31, 2013
|
Q2 FY2013
As of Apr 30, 2013
|
Q1 FY2013
As of Jan 31, 2013
|
Q4 FY2012
As of Oct 31, 2012
|
Q3 FY2012
As of Jul 31, 2012
|
Q2 FY2012
As of Apr 30, 2012
|
Q1 FY2012
As of Jan 31, 2012
|
Q3 FY2011
As of Jul 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets | |||||||||||||||
| Cash | |||||||||||||||
| Accounts receivable | |||||||||||||||
| Total inventory | |||||||||||||||
| Prepaid expenses and deposits | |||||||||||||||
| Total current assets | |||||||||||||||
| Net property and equipment | |||||||||||||||
| Patents, net | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and stockholders' equity | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Notes payable and accrued interest | |||||||||||||||
| Deferred revenue - current | |||||||||||||||
| Line of credit balance, components | |||||||||||||||
| Line of credit payable | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Total liabilities subject to compromise: | |||||||||||||||
| Notes payable and accrued interest - net | |||||||||||||||
| Total liabilities | |||||||||||||||
| Stockholders' equity | |||||||||||||||
| Preferred stock | |||||||||||||||
| Preferred stock - undesignated | |||||||||||||||
| Preferred stock - undesignated - $.005 par value per share, 350,000 shares authorized and none outstanding | |||||||||||||||
| Preferred stock - series A - $.005 par value per share, 150,000 shares authorized and 6,250 outstanding at April 30, 2015 and at October 31, 2014 | |||||||||||||||
| Class A common stock - $.005 par value per share, 300,000,000 shares authorized and 69,452,958 outstanding at April 30, 2015 and at October 31, 2014 | |||||||||||||||
| Total class A common stock - $.005 par value per share, 300,000,000 shares authorized and 69,452,958 outstanding at April 30, 2015 and at October 31, 2014 | |||||||||||||||
| Additional paid in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total stockholders' equity (deficit) | |||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||
Loading...
